Purchase Order 36C26024P1121
- Not listed
- This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The...
- This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract (Award ID: 36C26223P0309), with a ceiling value of $16,582.91, is a Firm Fixed Price Purchase Order placed under...
- This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Novocure's Optune Plus transducers, device rentals, and related support services. The $16,582.91 firm fixed-price delivery order was issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which was awarded in November 2022 and runs through October...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $49,748.73 firm-fixed-price delivery order contract to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical facilities nationwide. This delivery order is issued under Novocure's existing...
- This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is for the provision of Novocure's Optune Plus transducer devices, which utilize Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma, in VA medical facilities. The contract, which has a ceiling value of $49,748.73 and runs...
- This federal contract award is to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, to provide its Optune line of Tumor Treating Fields (TTFields) therapy products and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, a delivery order under a 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with a ceiling value of $28.85 million, has a ceiling value of $49,748.73 and a...
- This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The contract, valued at $49,748.73, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under its Federal Supply Schedule (FSS) program. The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related...
- This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order issued under a $28.85 million Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma at various VA medical centers...
- This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $45,600.00 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services to VA medical centers nationwide. The contract is part of a larger 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with a...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $16,582.91 firm-fixed-price delivery order contract to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy transducers, device rentals, and associated support services. This delivery order is issued under Novocure's $28.85 million, 5-year Federal Supply Schedule (FSS) contract...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $99,497.46, is a firm-fixed-price purchase order with a period of performance through January 16, 2025. Novocure is the prime contractor and no subcontractors are utilized. The contract is funded by the VA VHA and is not designated as a set-aside. Novocure holds a 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with the VA VHA, awarded in November 2022 with a ceiling value of $28.85 million. The current award is one of several delivery orders issued under this FSS contract, which provides a streamlined procurement vehicle for the VA to obtain Novocure's innovative cancer treatment technologies for distribution to VA medical centers nationwide. These contract awards support the VA's mission of expanding veterans' access to cutting-edge cancer therapies, such as Novocure's non-invasive TTFields therapy, which is FDA-approved for the treatment of glioblastoma and mesothelioma.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($50k) | 1/16/25 | |
| Not listed | Not listed | $149.2k | 8/30/24 |